Feasibility of Known RNA Polymerase Inhibitors as Anti-SARS-CoV-2 Drugs
Neogi, U.; Hill, K.J.; Ambikan, A.T.; Heng, X.; Quinn, T.P.; Byrareddy, S.N.; Sönnerborg, A.; Sarafianos, S.G.; Singh, K. Feasibility of Known RNA Polymerase Inhibitors as Anti-SARS-CoV-2 Drugs. Pathogens 2020, 9, 320. https://doi.org/10.3390/pathogens9050320
Neogi U, Hill KJ, Ambikan AT, Heng X, Quinn TP, Byrareddy SN, Sönnerborg A, Sarafianos SG, Singh K. Feasibility of Known RNA Polymerase Inhibitors as Anti-SARS-CoV-2 Drugs. Pathogens. 2020; 9(5):320. https://doi.org/10.3390/pathogens9050320
Chicago/Turabian StyleNeogi, Ujjwal, Kyle J. Hill, Anoop T. Ambikan, Xiao Heng, Thomas P. Quinn, Siddappa N. Byrareddy, Anders Sönnerborg, Stefan G. Sarafianos, and Kamal Singh. 2020. "Feasibility of Known RNA Polymerase Inhibitors as Anti-SARS-CoV-2 Drugs" Pathogens 9, no. 5: 320. https://doi.org/10.3390/pathogens9050320